156 related articles for article (PubMed ID: 33748101)
1. Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway.
Gao Y; Zheng H; Li L; Feng M; Chen X; Hao B; Lv Z; Zhou X; Cao Y
Front Cell Dev Biol; 2021; 9():598377. PubMed ID: 33748101
[TBL] [Abstract][Full Text] [Related]
2. Secreted phosphoprotein 1 promotes angiogenesis of glioblastoma through upregulating PSMA expression via transcription factor HIF1α.
Tu W; Zheng H; Li L; Zhou C; Feng M; Chen L; Li D; Chen X; Hao B; Sun H; Cao Y; Gao Y
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 55(3):417-425. PubMed ID: 36305723
[TBL] [Abstract][Full Text] [Related]
3. ALKBH5 is a prognostic factor and promotes the angiogenesis of glioblastoma.
Fan Y; Yan D; Ma L; Liu X; Luo G; Hu Y; Kou X
Sci Rep; 2024 Jan; 14(1):1303. PubMed ID: 38221546
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme.
Wernicke AG; Edgar MA; Lavi E; Liu H; Salerno P; Bander NH; Gutin PH
Arch Pathol Lab Med; 2011 Nov; 135(11):1486-9. PubMed ID: 22032578
[TBL] [Abstract][Full Text] [Related]
5. RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways.
Wang M; Zhang C; Zheng Q; Ma Z; Qi M; Di G; Ling S; Xu H; Qi B; Yao C; Xia H; Jiang X
Int J Biol Sci; 2022; 18(3):942-955. PubMed ID: 35173528
[TBL] [Abstract][Full Text] [Related]
6. Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer.
Morgenroth A; Tinkir E; Vogg ATJ; Sankaranarayanan RA; Baazaoui F; Mottaghy FM
Breast Cancer Res; 2019 Oct; 21(1):116. PubMed ID: 31640747
[TBL] [Abstract][Full Text] [Related]
7. Prostate-Specific Membrane Antigen Expression in Neovasculature of Glioblastoma Multiforme.
Mahzouni P; Shavakhi M
Adv Biomed Res; 2019; 8():18. PubMed ID: 30993088
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.
Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W
Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361
[TBL] [Abstract][Full Text] [Related]
9. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
[TBL] [Abstract][Full Text] [Related]
11. Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment.
Nguyen DP; Xiong PL; Liu H; Pan S; Leconet W; Navarro V; Guo M; Moy J; Kim S; Ramirez-Fort MK; Batra JS; Bander NH
Mol Cancer Res; 2016 Nov; 14(11):1045-1053. PubMed ID: 27458033
[TBL] [Abstract][Full Text] [Related]
12. PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging.
Holzgreve A; Biczok A; Ruf VC; Liesche-Starnecker F; Steiger K; Kirchner MA; Unterrainer M; Mittlmeier L; Herms J; Schlegel J; Bartenstein P; Tonn JC; Albert NL; Suchorska B
Front Oncol; 2021; 11():646387. PubMed ID: 33859946
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-Prostate-Specific Membrane Antigen-11 PET/CT: A New Imaging Option for Recurrent Glioblastoma Multiforme?
Kunikowska J; Kuliński R; Muylle K; Koziara H; Królicki L
Clin Nucl Med; 2020 Jan; 45(1):11-18. PubMed ID: 31663868
[TBL] [Abstract][Full Text] [Related]
14. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
[TBL] [Abstract][Full Text] [Related]
15. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of microRNA-16 in Glioblastoma Inhibits the Function of Endothelial Cells and Tumor Angiogenesis by Targeting Bmi-1.
Chen F; Chen L; He H; Huang W; Zhang R; Li P; Meng Y; Jiang X
Anticancer Agents Med Chem; 2016; 16(5):609-20. PubMed ID: 26373393
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
18. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
[TBL] [Abstract][Full Text] [Related]
19. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
